Reply by Authors

Pearce et al are looking for a platform to let the urology community know about their observations regarding long-term use of PPS (Elmiron ®) and potential ophthalmological complications, so much so that they have used a letter to the editor concerning our recent article on the FDA BRUDAC (Bone, Reproductive and Urologic Drugs Advisory Committee) criteria for interstitial cystitis/bladder pain syndrome as a pretext. While their letter has nothing at all to do with our article, we are happy that they have a chance to present their observations.
Source: The Journal of Urology - Category: Urology & Nephrology Tags: Letter to the Editor/Errata Source Type: research